Evaluation of SHOX defects in the era of next-generation sequencing
Carregando...
Citações na Scopus
9
Tipo de produção
article
Data de publicação
2019
Título da Revista
ISSN da Revista
Título do Volume
Editora
WILEY
Citação
CLINICAL GENETICS, v.96, n.3, p.261-265, 2019
Resumo
Short stature homeobox (SHOX) haploinsufficiency is a frequent cause of short stature. Despite advances in sequencing technologies, the identification of SHOX mutations continues to be performed using standard methods, including multiplex ligation-dependent probe amplification (MLPA) followed by Sanger sequencing. We designed a targeted panel of genes associated with growth impairment, including SHOX genomic and enhancer regions, to improve the resolution of next-generation sequencing for SHOX analysis. We used two software packages, CONTRA and Nexus Copy Number, in addition to visual analysis to investigate the presence of copy number variants (CNVs). We evaluated 15 patients with previously known SHOX defects, including point mutations, deletions and a duplication, and 77 patients with idiopathic short stature (ISS). The panel was able to confirm all known defects in the validation analysis. During the prospective evaluation, we identified two new partial SHOX deletions (one detected only by visual analysis), including an intragenic deletion not detected by MLPA. Additionally, we were able to determine the breakpoints in four cases. Our results show that the designed panel can be used for the molecular investigation of patients with ISS, and it may even detect CNVs in SHOX and its enhancers, which may be present in a significant fraction of patients.
Palavras-chave
copy number variants, growth disorder, next-generation sequencing, short stature, SHOX gene, targeted panel sequencing
Referências
- Benito-Sanz S, 2017, J HUM GENET, V62, P229, DOI 10.1038/jhg.2016.113
- Benito-Sanz S, 2012, J MED GENET, V49, P442, DOI 10.1136/jmedgenet-2011-100678
- BINDER G, 2015, GENETIC REV, DOI 10.1038/NMETH0410-248
- Blum WF, 2013, J CLIN ENDOCR METAB, V98, pE1383, DOI 10.1210/jc.2013-1222
- DARVISHI K, 2010, CURR PROTOC HUM GENE, V65, DOI 10.1002/0471142905.HG0414S65
- Freire BL, 2019, J CLIN ENDOCR METAB, V104, P2023, DOI 10.1210/jc.2018-01971
- Funari MFA, 2010, EUR J MED GENET, V53, P234, DOI 10.1016/j.ejmg.2010.06.001
- Funari MFA, 2008, ARQ BRAS ENDOCRINOL, V52, P1382, DOI 10.1590/S0004-27302008000800029
- Hauer NN, 2018, GENET MED, V20, P630, DOI 10.1038/gim.2017.159
- Krumm N, 2012, GENOME RES, V22, P1525, DOI 10.1101/gr.138115.112
- Li J, 2012, BIOINFORMATICS, V28, P1307, DOI 10.1093/bioinformatics/bts146
- Marchini A, 2016, ENDOCR REV, V37, P417, DOI 10.1210/er.2016-1036
- Tattini Lorenzo, 2015, Front Bioeng Biotechnol, V3, P92, DOI 10.3389/fbioe.2015.00092